See other bills
under the
same topic
                                                       PRINTER'S NO. 873

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 784 Session of 2001


        INTRODUCED BY BEBKO-JONES, BELARDI, YOUNGBLOOD, C. WILLIAMS,
           WASHINGTON, WALKO, TRELLO, DALEY, COY, COSTA, CORRIGAN,
           LAUGHLIN, READSHAW, ORIE, JAMES, HORSEY, HENNESSEY, THOMAS,
           TANGRETTI, MELIO, BELFANTI, MANDERINO, SCRIMENTI, SOLOBAY,
           STEELMAN, HARHAI, GEORGE AND FREEMAN, FEBRUARY 20, 2001

        REFERRED TO COMMITTEE ON INSURANCE, FEBRUARY 20, 2001

                                     AN ACT

     1  Requiring health insurance providers which furnish coverage for
     2     prescription drugs to extend coverage to off-label use of
     3     drugs; and imposing a penalty.

     4     The General Assembly of the Commonwealth of Pennsylvania
     5  hereby enacts as follows:
     6  Section 1.  Short title.
     7     This act shall be known and may be cited as the Off-label Use
     8  of Drugs Coverage Act.
     9  Section 2.  Definitions.
    10     The following words and phrases when used in this act shall
    11  have the meanings given to them in this section unless the
    12  context clearly indicates otherwise:
    13     "Commissioner."  The Insurance Commissioner of the
    14  Commonwealth.
    15     "Department."  The Insurance Department of the Commonwealth.
    16     "Health insurance."  Any policy, contract or plan which
    17  provides medical coverage on an expense-incurred service or

     1  prepaid basis or an employee welfare benefit plan issued or
     2  subject to any of the following laws:
     3         (1)  The act of May 17, 1921 (P.L.682, No.284), known as
     4     The Insurance Company Law of 1921.
     5         (2)  The act of December 29, 1972 (P.L.1701, No.364),
     6     known as the Health Maintenance Organization Act.
     7         (3)  The act of May 18, 1976 (P.L.123, No.54), known as
     8     the Individual Accident and Sickness Insurance Minimum
     9     Standards Act.
    10         (4)  The act of December 14, 1992 (P.L.835, No.134),
    11     known as the Fraternal Benefit Societies Code.
    12         (5)  40 Pa.C.S. Ch. 61 (relating to hospital plan
    13     corporations) or 63 (relating to professional health services
    14     plan corporations).
    15         (6)  The Employee Retirement Income Security Act of 1974
    16     (P.L. 93-406, 88 Stat. 829).
    17     "Medical literature."  A peer-reviewed, national medical or
    18  scientific journal.
    19     "Off-label use of drugs."  Prescribing a drug for treatment
    20  of a condition other than a condition specifically approved for
    21  treatment by the Food and Drug Administration.
    22     "Secretary."  The Secretary of Health of the Commonwealth.
    23     "Standard reference compendia."  The American Medical
    24  Association Drug Evaluation, the American Hospital Formulary
    25  Service Drug Information or the United States Pharmacopeia Drug
    26  Information.
    27  Section 3.  Coverage for off-label use of drugs required.
    28     Health insurance which provides coverage for prescription
    29  drugs may not exclude coverage of a drug for a particular
    30  indication on the grounds that the drug has not been approved by
    20010H0784B0873                  - 2 -

     1  the Food and Drug Administration for that indication if the drug
     2  is recognized for treatment of the indication in one of the
     3  standard reference compendia or in medical literature.
     4  Section 4.  Review of off-label uses of drugs.
     5     The secretary shall appoint a panel of eight qualified
     6  medical experts to review off-label uses of drugs not included
     7  in the standard reference compendia or medical literature. The
     8  panel shall advise the commissioner whether a particular off-
     9  label use is medically appropriate and shall make
    10  recommendations regarding payment of off-label use.
    11  Section 5.  Enforcement.
    12     The department shall enforce the provisions of this act.
    13  Section 6.  Penalty.
    14     A provider of health insurance that violates this act shall
    15  be subject to a civil penalty of $1,000.
    16  Section 19.  Construction of act.
    17     Nothing in this act shall be construed to require coverage
    18  for experimental drugs not otherwise approved for any indication
    19  by the Food and Drug Administration.
    20  Section 20.  Effective date.
    21     This act shall take effect in 60 days.






    A17L40VDL/20010H0784B0873        - 3 -